ArticleNuclear medicine communications2020

A theranostic approach based on radiolabeled antiviral drugs, antibodies and CRISPR-associated proteins for early detection and treatment of SARS-CoV-2 disease.

Isaac Shiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.